Michael Gordon
MD
Medical Oncologist
👥Biography 个人简介
Michael Gordon has contributed to clinical development of ramucirumab (VEGFR-2 antibody) in gastric, lung, and colorectal cancers through leadership of pivotal trials including the REGARD trial in gastric cancer. His extensive participation in early phase anti-angiogenic cancer trials has contributed to the evidence base for multiple anti-VEGFR drugs.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Michael Gordon 的研究动态
Follow Michael Gordon's research updates
留下邮箱，当我们发布与 Michael Gordon（Scottsdale Healthcare Research Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment